89 results on '"Marsh NA"'
Search Results
2. The mechanical effects of rhinoceros horned viper (Bitis nasicornis) venom on the isolated perfused guinea-pig heart
- Author
-
Alloatti, G, primary, Gattullo, D, additional, Losano, G, additional, Marsh, NA, additional, Pagliaro, P, additional, and Vono, P, additional
- Published
- 1991
- Full Text
- View/download PDF
3. The Kidney and Fibrinolysis
- Author
-
Marsh Na
- Subjects
medicine.medical_specialty ,Kidney ,Endocrinology ,medicine.anatomical_structure ,business.industry ,Internal medicine ,medicine.medical_treatment ,Fibrinolysis ,medicine ,Hematology ,business - Abstract
SummaryMolecular exclusion chromatography was performed on samples of urine from normal and aminonucleoside nephrotic rats. Normal urine contained 2 peaks of urokinase activity, one having a molecular weight of 22,000 and the other around 200,000. Nephrotic urine contained three peaks of activity with MW’s 126,000, 60,000 and 30,000. Plasma activator determined from euglobulin precipitate had a MW. in excess of 200,000. The results indicate that in the normal animal, plasma plasminogen activator does not escape into the urine in substantial quantities but under the conditions of extreme proteinuria there may be some loss through the kidney. The alteration in urokinase output in nephrotic animals indicates a greatly disordered renal fibrinolytic enzyme system.The findings of this study largely support the hypothesis that plasma plasminogen activator of renal origin and urinary plasminogen activator (urokinase) are different molecular species.
- Published
- 1970
4. Isolated tears of the sternocostal head of the pectoralis major muscle: surgical technique, clinical outcomes, and a modification of the Tietjen and Bak classification.
- Author
-
Marsh NA, Calcei JG, Antosh IJ, and Cordasco FA
- Subjects
- Adult, Clavicle, Female, Humans, Male, Middle Aged, Patient Satisfaction, Return to Sport, Rupture surgery, Treatment Outcome, Pectoralis Muscles injuries, Pectoralis Muscles surgery, Suture Techniques
- Abstract
Hypothesis: We aimed to describe a modified surgical technique to treat isolated sternocostal head tears using cortical button fixation while preserving the intact clavicular head tendon, to outline a new classification of pectoralis major injuries, and to present the clinical outcomes and return-to-sport data of a cohort of 21 athletes who underwent surgical repair., Methods: We reviewed prospectively collected data of patients who underwent surgical repair with the described technique for isolated sternocostal head tears from 2008 to 2014. Two-year postoperative clinical outcomes including the Single Assessment Numeric Evaluation score, isokinetic strength, patient satisfaction, and return to sport, as well as preinjury and postoperative bench-press weight, were collected, and descriptive statistics were used for analysis., Results: Twenty-one patients who underwent repair of isolated sternocostal head tears were included. The majority of the isolated tears of the sternocostal head of the pectoralis major (57%) occurred during the bench press. Of the ruptures, 81% were Tietjen type IIIC and 19% were type IIID. Postoperative Single Assessment Numeric Evaluation scores averaged 90.1 (standard deviation, 8.4), and patient satisfaction was 9.5 of 10 (standard deviation, 0.9). All athletes returned to sport approximately 5.5 months postoperatively. The isokinetic strength deficit averaged 8% compared with the contralateral arm, whereas the average preinjury bench-press weight of 134 kg (range 88-227 kg) was restored to 117 kg (range 61-250 kg) postoperatively., Conclusion: We propose a new classification of pectoralis major injury. In addition, we present a biomechanically sound repair technique for isolated tears of the sternocostal head of the pectoralis with favorable outcomes. The technique takes the specific anatomy of the sternocostal and clavicular heads into account for the approach., (Copyright © 2019 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
5. Likelihood of Return to Duty Is Low After Meniscal Allograft Transplantation in an Active-duty Military Population.
- Author
-
Antosh IJ, Cameron KL, Marsh NA, Posner MA, DeBerardino TM, Svoboda SJ, and Owens BD
- Subjects
- Adult, Allografts, Female, Graft Survival, Humans, Male, Recovery of Function, Retrospective Studies, Menisci, Tibial transplantation, Military Personnel, Return to Work, Tibial Meniscus Injuries surgery
- Abstract
Background: Meniscal allograft transplantation (MAT) is considered a viable surgical treatment option in the symptomatic, postmeniscectomy knee and as a concomitant procedure with ACL revision and articular cartilage repair. Although promising outcomes have recently been reported in active and athletic populations, MAT has not been well-studied in the high-demand military population., Questions/purposes: (1) What proportion of active-duty military patients who underwent MAT returned to full, unrestricted duty? (2) What demographic and surgical variables, if any, correlated with return to full, unrestricted duty?, Methods: Between 2005 and 2015, three fellowship-trained sports surgeons (TMD, SJS, BDO) performed 110 MAT procedures in active-duty military patients, of which 95% (104 patients) were available for follow-up at a minimum 2 years (mean 2.8 ± SD 1.1 year). During the study period, indications for MAT generally included unicompartmental pain and swelling in a postmeniscectomized knee and as a concomitant procedure when a meniscal-deficient compartment was associated with either an ACL revision reconstruction or cartilage repair. Demographic and surgical variables were collected and analyzed. The primary endpoints were the decision for permanent profile activity restrictions and military duty termination by a medical board. The term "medical board" implies termination of military service because of medical reasons. We elected to set statistical significance at p < 0.001 to reduce the potential for spurious statistical findings in the setting of a relatively small sample size., Results: Forty-six percent (48 of 104) of eligible patients had permanent profile activity restrictions and 50% (52 of 104) eventually had their military duty terminated by a military board. Only 20% (21 of 104) had neither permanent profile activity restrictions nor medical-board termination and were subsequently able to return to full duty, and only 13% (13 of 104) continued unrestricted military service beyond 2 years after surgery. Age, gender, tobacco use, and BMI did not correlate with return to full duty. Combat arms soldiers were less likely to have permanent profile activity restrictions (odds ratio 4.76 [95% confidence interval 1.93 to 11.8]; p = 0.001) and were more likely to return to full duty than soldiers in support roles (OR 0.24 [95% CI 0.09 to 0.65]; p = 0.005), although these findings did not reach statistical significance. Officers were more likely to return to full duty than enlisted soldiers at more than 2 years after surgery (OR 17.44 [95% CI 4.56 to 66.65]; p < 0.001). No surgical variables correlated with return-to-duty endpoints., Conclusions: Surgeons should be aware of the low likelihood of return to military duty at more than 2 years after MAT and counsel patients accordingly. Based on this study, MAT does not appear to be compatible with continued unrestricted military duty for most patients., Level of Evidence: IV, therapeutic study.
- Published
- 2020
- Full Text
- View/download PDF
6. Labral hypertrophy correlates with borderline hip dysplasia and microinstability in femoroacetabular impingement: a matched case-control analysis.
- Author
-
Nwachukwu BU, Gaudiani MA, Marsh NA, and Ranawat AS
- Subjects
- Adult, Arthroscopy, Case-Control Studies, Cohort Studies, Female, Femoracetabular Impingement surgery, Hip Dislocation surgery, Humans, Hypertrophy, Male, Physical Examination, Radiography, Range of Motion, Articular, Young Adult, Acetabulum pathology, Femoracetabular Impingement complications, Femoracetabular Impingement pathology, Hip Dislocation complications, Hip Dislocation pathology
- Abstract
Purpose:: The goal of this study was to: (1) investigate the association between labral hypertrophy and radiographic and computed tomography (CT) imaging measurements of dysplasia in a femoroacetabular impingement (FAI) cohort; (2) evaluate the association between physical examination parameters suggestive of microinstability and labral hypertrophy., Methods:: A retrospective case-control study was performed. Labral hypertrophy was defined as intraoperative labral width measuring greater >4 mm. A control cohort (NL) was matched to the cases. Physical examination parameters and preoperative radiographic and CT imaging studies were reviewed., Results:: 231 hip arthroscopies for FAI were reviewed from which 42 cases of labral hypertrophy were identified (LH). In the LH group there was significantly increased hip internal rotation at 90° hip flexion compared to normal controls (13.6° ± 1 0.7° LH vs. 9.3° ± 6.2° NL; p = 0.04). On plain radiographs, the mean lateral centre-edge angle was smaller in the LH group compared to the NL group (27.6° ± 6.00° LH vs. 31.6° ± 6.59° NL; p < 0.001) and the acetabular index was larger in the LH group compared to the NL group (6.61 ± 4.18 LH vs. 4.14 ± 6.13 NL; p = 0.04). On CT imaging coronal sagittal CEA was significantly lower in LH cases compared to NL control (31.8° ± 5.30° LH vs. 35.1° ± 7.67° NL; p = 0.01)., Conclusions:: We found that patients with labral hypertrophy have radiographic and CT measurements consistent with subtle but not absolute dysplasia and physical examination findings suggestive of microinstability. We propose that labral hypertrophy can be a useful clinical tool for identifying FAI patients on the dysplasia spectrum.
- Published
- 2019
- Full Text
- View/download PDF
7. Tibial Interference Screw Positioning Relative to the Bone Plug in ACL Reconstruction: A Biomechanical Comparison of Cortical Versus Cancellous-Sided Placement.
- Author
-
Marsh NA, Antosh IJ, O'Conor DK, Ortega RJ, Paneral NS, Cameron KL, and Posner M
- Subjects
- Animals, Biomechanical Phenomena, Cancellous Bone, Cortical Bone, Swine, Anterior Cruciate Ligament surgery, Bone Screws, Bone-Patellar Tendon-Bone Grafting methods, Tibia surgery
- Abstract
The biomechanical strength of a bone-patellar tendon-bone graft in the tibia may vary depending on whether the interference screw abuts the cancellous vs the cortical surface of the bone plug. In a porcine model, 10×20-mm bone-patellar tendon-bone grafts were prepared and fixed in a 10-mm diameter tibial tunnel using a 9×25-mm titanium interference screw. The screw was positioned on the cancellous surface of the graft in group A (n=13) vs the cortical side of the graft in group B (n=14). Specimens underwent precycling, cyclic loading, and load-to-failure testing. The mean ultimate failure load was 493±245 N for group A vs 304±145 N for group B (P=.008). Sixty-nine percent of specimens in group A survived 1000 cycles of load testing compared with 21% of specimens in group B. Forty-three percent of specimens in group B sustained intratendinous failure adjacent to the bone plug compared with 15% of specimens in group A. Orientation of the tibial interference screw along the cancellous vs the cortical side of the graft results in superior cyclic loading and ultimate failure load characteristics. Additionally, screw placement along the cortical side may weaken the tendon interface and lead to tendon failure under load. This study indicates that placement of the tibial interference screw along the cancellous side of the graft is biomechanically favorable. However, the clinical ramifications of these findings are not clear. [Orthopedics. 2018; 41(6):337-342.]., (Copyright 2018, SLACK Incorporated.)
- Published
- 2018
- Full Text
- View/download PDF
8. Investigation of factors relating to neuropsychological change following cardiac surgery.
- Author
-
Raymond PD, Radel M, Ray MJ, Hinton-Bayre AD, and Marsh NA
- Subjects
- Age Factors, Aged, Cognition Disorders diagnosis, Elective Surgical Procedures, Female, Heparin blood, Humans, Male, Middle Aged, Peptide Fragments blood, Postoperative Period, Prothrombin, Risk Factors, Cognition Disorders etiology, Coronary Artery Bypass adverse effects, Neuropsychological Tests
- Abstract
Background: An analysis of neuropsychological impairment following cardiopulmonary bypass was performed in 55 patients undergoing elective coronary artery bypass grafting., Methods: Neurocognitive function was measured preoperatively using the MicroCog: Assessment of Cognitive Functioning computer-based testing tool. Testing was repeated in the postoperative period immediately prior to discharge from hospital. Analysis of significant score decline was performed using the standardised regression-based technique. A patient was classified as overall impaired when > or = 20% of test scores were significantly impaired. The proposed marker of neurological damage S-100beta was also used. Prothrombin Fragment 1+2 (F1+2) was measured as a marker of thrombin development to test the hypothesis that excessive haemostatic activation may lead to thromboembolic damage to the brain., Results and Conclusions: 32.7% of patients were classified as significantly impaired. No relationship was detected between F1+2 and any neuropsychological test score; however, the study was limited due to small sample size. F1+2 levels were higher in patients undergoing prolonged bypass times. Neuropsychological decline was significantly correlated with patient age, suggesting a degree of caution is warranted when operating on an elderly cohort. An unexpected relationship was detected between higher heparin concentrations and increased risk of neuropsychological impairment; however, this requires re-evaluation.
- Published
- 2007
- Full Text
- View/download PDF
9. Test-retest norms and reliable change indices for the MicroCog Battery in a healthy community population over 50 years of age.
- Author
-
Raymond PD, Hinton-Bayre AD, Radel M, Ray MJ, and Marsh NA
- Subjects
- Aged, Aged, 80 and over, Confidence Intervals, Female, Humans, Male, Middle Aged, Reference Values, Regression Analysis, Reproducibility of Results, Time Factors, Cognition physiology, Neuropsychological Tests, Residence Characteristics
- Abstract
The increasing availability of computerized test batteries used to assess neuropsychological changes requires the availability of suitable test-retest normative data. Reliable change indices can then be used to evaluate significance of change in an individual's performance on retesting. We tested (N = 40) neurologically normal adults on three occasions (initially, two weeks, and three months) on the MicroCog: Assessment of Cognitive Functioning computerized testing instrument. Normative retest data are presented for two analytic techniques: the Reliable Change Index adjusted for practice and the Standardized Regression-Based technique. At two weeks, the correlation coefficients ranged from .49 to .84, with all scores demonstrating significant practice effects. At 3 months, coefficients ranged from .50 to .83, with all scores except Attention / Mental Control demonstrating significant practice compared to baseline. Regression equations were generated for all scores using age, sex, education level, and score at Time 1 as predictors. For all measures the only significant predictor was the Time 1 score. The reliable change indices and regression equations presented here can be used to determine the significance of change from predicted retest scores in a matched interventional cohort.
- Published
- 2006
- Full Text
- View/download PDF
10. Assessment of statistical change criteria used to define significant change in neuropsychological test performance following cardiac surgery.
- Author
-
Raymond PD, Hinton-Bayre AD, Radel M, Ray MJ, and Marsh NA
- Subjects
- Aged, Aged, 80 and over, Case-Control Studies, Cognition Disorders etiology, Cohort Studies, Female, Humans, Male, Middle Aged, Models, Statistical, Postoperative Period, Cognition Disorders diagnosis, Coronary Artery Bypass adverse effects, Neuropsychological Tests statistics & numerical data
- Abstract
Objective: This paper compares four techniques used to assess change in neuropsychological test scores before and after coronary artery bypass graft surgery (CABG), and includes a rationale for the classification of a patient as overall impaired., Methods: A total of 55 patients were tested before and after surgery on the MicroCog neuropsychological test battery. A matched control group underwent the same testing regime to generate test-retest reliabilities and practice effects. Two techniques designed to assess statistical change were used: the Reliable Change Index (RCI), modified for practice, and the Standardised Regression-based (SRB) technique. These were compared against two fixed cutoff techniques (standard deviation and 20% change methods)., Results: The incidence of decline across test scores varied markedly depending on which technique was used to describe change. The SRB method identified more patients as declined on most measures. In comparison, the two fixed cutoff techniques displayed relatively reduced sensitivity in the detection of change., Conclusions: Overall change in an individual can be described provided the investigators choose a rational cutoff based on likely spread of scores due to chance. A cutoff value of > or =20% of test scores used provided acceptable probability based on the number of tests commonly encountered. Investigators must also choose a test battery that minimises shared variance among test scores.
- Published
- 2006
- Full Text
- View/download PDF
11. Increased platelet-derived microparticles in the coronary circulation of percutaneous transluminal coronary angioplasty patients.
- Author
-
Craft JA, Masci PP, Roberts MS, Brighton TA, Garrahy P, Cox S, and Marsh NA
- Subjects
- Antithrombin III analysis, Cardiovascular Agents therapeutic use, Combined Modality Therapy, Coronary Circulation, Coronary Restenosis etiology, Coronary Stenosis drug therapy, Coronary Stenosis therapy, Coronary Vessels, Female, Humans, Integrin beta3 analysis, L-Lactate Dehydrogenase blood, Leukocyte Count, Male, Middle Aged, Particle Size, Peptide Hydrolases analysis, Platelet Adhesiveness, Platelet Count, Stents, Thromboxane B2 blood, Angioplasty, Balloon, Coronary, Blood Platelets ultrastructure, Coronary Stenosis blood
- Abstract
Platelet-derived microparticles that are produced during platelet activation are capable of adhesion and aggregation. Endothelial trauma that occurs during percutaneous transluminal coronary angioplasty (PTCA) may support platelet-derived microparticle adhesion and contribute to development of restenosis. We have previously reported an increase in platelet-derived microparticles in peripheral arterial blood with angioplasty. This finding raised concerns regarding the role of platelet-derived microparticles in restenosis, and therefore the aim of this study was to monitor levels in the coronary circulation. The study population consisted of 19 angioplasty patients. Paired coronary artery and sinus samples were obtained following heparinization, following contrast administration, and subsequent to all vessel manipulation. Platelet-derived microparticles were identified with an anti-CD61 (glycoprotein IIIa) fluorescence-conjugated antibody using flow cytometry. There was a significant decrease in arterial platelet-derived microparticles from heparinization to contrast administration (P = 0.001), followed by a significant increase to the end of angioplasty (P = 0.004). However, there was no significant change throughout the venous samples. These results indicate that the higher level of platelet-derived microparticles after angioplasty in arterial blood remained in the coronary circulation. Interestingly, levels of thrombin-antithrombin complexes did not rise during PTCA. This may have implications for the development of coronary restenosis post-PTCA, although this remains to be determined.
- Published
- 2004
- Full Text
- View/download PDF
12. Increased generation of platelet-derived microparticles following percutaneous transluminal coronary angioplasty.
- Author
-
Craft JA and Marsh NA
- Subjects
- Abciximab, Blood Platelets drug effects, Female, Humans, Male, Middle Aged, Angioplasty, Balloon, Coronary adverse effects, Antibodies, Monoclonal therapeutic use, Blood Platelets physiology, Immunoglobulin Fab Fragments therapeutic use, Platelet Aggregation Inhibitors therapeutic use
- Abstract
Platelet-derived microparticles that are produced during platelet activation bind to traumatized endothelium. Such endothelial injury occurs during percutaneous transluminal coronary angioplasty. Approximately 20% of these patients subsequently develop restenosis, although this is improved by treatment with the anti-platelet glycoprotein IIb/IIIa receptor drug abciximab. As platelet activation occurs during angioplasty, it is likely that platelet-derived microparticles may be produced and hence contribute to restenosis. This study population consisted of 113 angioplasty patients, of whom 38 received abciximab. Paired peripheral arterial blood samples were obtained following heparinization and subsequent to all vessel manipulation. Platelet-derived microparticles were identified using an anti-CD61 (glycoprotein IIIa) fluorescence-conjugated antibody and flow cytometry. Baseline clinical characteristics between patient groups were similar. The level of platelet-derived microparticles increased significantly following angioplasty in the group without abciximab (paired t test, P = 0.019). However, there was no significant change in the level of platelet-derived microparticles following angioplasty in patients who received abciximab, despite requiring more complex angioplasty procedures. In this study, we have demonstrated that the level of platelet-derived microparticles increased during percutaneous transluminal coronary angioplasty, with no such increase with abciximab treatment. The increased platelet-derived microparticles may adhere to traumatized endothelium, contributing to re-occlusion of the arteries, but this remains to be determined.
- Published
- 2003
- Full Text
- View/download PDF
13. Heparin monitoring during cardiac surgery. Part 2: Calculating the overestimation of heparin by the activated clotting time.
- Author
-
Raymond PD, Ray MJ, Callen SN, and Marsh NA
- Subjects
- Aged, Blood Coagulation Tests standards, Coronary Artery Bypass, Drug Monitoring methods, Elective Surgical Procedures, Factor Xa Inhibitors, Heparin pharmacokinetics, Humans, Middle Aged, Models, Theoretical, Pharmacokinetics, Whole Blood Coagulation Time standards, Cardiac Surgical Procedures, Drug Monitoring standards, Heparin blood
- Abstract
Activated clotting time (ACT) values were converted to heparin concentration, enabling an assessment of the accuracy of the ACT and a quantification of the prolongation imposed by bypass. Blood samples were obtained from 42 adult cardiopulmonary bypass (CPB) patients before and during bypass surgery. Samples were analysed for ACT (HemoTec ACT) and anti-factor Xa (anti-Xa) plasma heparin concentration. The mean heparin concentration calculated before bypass was an accurate reflection of plasma heparin; however, calculated values rose to around 170% of anti-Xa values upon connection to bypass. By adjusting for this rise, for 95% of cases the calculated heparin concentration would vary between 0.60 and 1.65 times anti-Xa values. Without accounting for artificial prolongation or individual sensitivities, the ACT may give values between 0.8 and 3.0 times that indicated by the anti-Xa assay. When both individual heparin sensitivities and the effects of bypass are considered, the ACT may provide a more suitable indication of heparin levels; however, typical use may overestimate heparin up to threefold.
- Published
- 2003
- Full Text
- View/download PDF
14. Heparin monitoring during cardiac surgery. Part 1: Validation of whole-blood heparin concentration and activated clotting time.
- Author
-
Raymond PD, Ray MJ, Callen SN, and Marsh NA
- Subjects
- Aged, Blood Coagulation Tests instrumentation, Blood Coagulation Tests standards, Coronary Artery Bypass, Drug Monitoring standards, Elective Surgical Procedures, Factor Xa Inhibitors, Heparin pharmacokinetics, Humans, Middle Aged, Pharmacokinetics, Whole Blood Coagulation Time instrumentation, Whole Blood Coagulation Time standards, Cardiac Surgical Procedures, Drug Monitoring methods, Heparin blood
- Abstract
There is limited published data on the agreement between techniques for monitoring heparin levels. The aim of this study was to validate the Hepcon/HMS, with particular focus on the agreement with laboratory anti-Xa assay. The performances of two ACT instruments--Hemochron and HemoTec--were also evaluated, including an assessment for interchangeability. Blood samples from 42 adult cardiopulmonary bypass (CPB) patients were analysed for activated clotting time (ACT), whole-blood heparin concentration (Hepcon/HMS) and anti-factor Xa (anti-Xa) plasma heparin concentration. Agreement between measures was determined using the method of Bland and Altman. Simple analysis of agreement between the Hepcon and anti-Xa heparin revealed the Hepcon has a mean bias of -0.46 U/mL, with the limits of agreement +/- 1.12 U/mL. The comparison between ACT instruments indicated a mean difference of -96 seconds for the HemoTec, with limits of +/- 265 seconds. The Hepcon/ HMS instrument displayed satisfactory agreement with anti-Xa plasma heparin concentration, as the expected variation would not be expected to cause problems in the clinical setting. Agreement between the two measurements of ACT may be satisfactory, provided each is assigned a different target value.
- Published
- 2003
- Full Text
- View/download PDF
15. Alterations to haemostasis following cardiopulmonary bypass and the relationship of these changes to neurocognitive morbidity.
- Author
-
Raymond PD and Marsh NA
- Subjects
- Cardiopulmonary Bypass methods, Cardiopulmonary Bypass standards, Cerebrovascular Disorders blood, Cerebrovascular Disorders epidemiology, Cerebrovascular Disorders etiology, Cognition Disorders blood, Cognition Disorders epidemiology, Humans, Incidence, Intracranial Embolism and Thrombosis blood, Intracranial Embolism and Thrombosis epidemiology, Intracranial Embolism and Thrombosis etiology, Cardiopulmonary Bypass adverse effects, Cognition Disorders etiology, Hemostasis physiology
- Abstract
Cardiopulmonary bypass (CPB) is routinely utilized to provide circulatory support during cardiac surgical procedures. The morbidity of CPB has been significantly reduced since its introduction 50 years ago; however, cerebral injury remains a potentially serious consequence of otherwise successful surgery. The risk of stroke postoperatively is approximately 1-5%. Incidence rates for neurocognitive deficit, however, vary markedly depending on the detection method, although typically it is reported in at least 50% of patients. The aetiology of this cerebral injury remains open to debate, although evidence shows that ischaemia secondary to microembolism may be the principal factor. Emboli originate from bubbles of air, atheroemboli released on aortic manipulation and thromboemboli generated as a result of haemostatic activation. Significant generation of thrombin occurs during CPB resulting in fibrin formation, although the trigger of this activation is not fully understood. Rather than originating from contact activation as previously thought, the primary trigger may be via the activated factor VII/tissue factor pathway of coagulation, with an additional role of contact activation in amplification of coagulation as well as the fibrinolytic response to CPB. Haemostatic activation is inhibited with systemic heparin therapy. The relationship between haemostatic activation and emboli formation during CPB is not known. Interventions to reduce cerebral injury in the context of cardiac surgery depend, in large part, on the minimization of emboli. This review investigates cerebral injury after cardiac surgery and evidence showing that microembolism is the principal causative agent. Fibrin emboli are postulated to be an important source of cerebral embolism. The mechanism of haemostatic activation during CPB is therefore also discussed.
- Published
- 2001
- Full Text
- View/download PDF
16. Diagnostic uses of snake venom.
- Author
-
Marsh NA
- Subjects
- Animals, Anticoagulants, Blood Coagulation Tests, Coagulants, Hemostasis drug effects, Humans, Snake Venoms
- Abstract
Snake venom toxins are invaluable for the assay of coagulation factors and for the study of haemostasis generally. Thrombin-like enzymes (SVTLE) are used for fibrinogen and fibrinogen breakdown product assays as well as detecting dysfibrinogenaemias. Since SVTLE are not inhibited by heparin, they can be used for assaying antithrombin III in samples containing heparin. Snake venom prothrombin activators are utilised in prothrombin assays, whilst Russell's viper venom (RVV) can be used to assay clotting factors V, VII, X and lupus anticoagulants (LA). Activators from the taipan, Australian brown snake and saw-scaled viper have also been used to assay LA. Protein C (PC) and activated PC (APC) resistance can be measured by means of RVV, Protac (from Southern copperhead snake venom) and STA-Staclot (from Crotalus viridis helleri) whilst von Willebrand factor can be studied with Botrocetin (Bothrops jararaca). Finally, snake venom C-type lectins and metalloproteinase disintegrins are being used to study platelet glycoprotein receptors and show great potential for use in the routine coagulation laboratory., (Copyright 2002 S. Karger AG, Basel)
- Published
- 2001
- Full Text
- View/download PDF
17. The factor V HR2 haplotype: prevalence and association of the A4070G and A6755G polymorphisms.
- Author
-
Pecheniuk NM, Morris CP, Walsh TP, and Marsh NA
- Subjects
- Alleles, Blood Donors, Cohort Studies, Deoxyribonucleases, Type II Site-Specific metabolism, Factor V chemistry, Factor V metabolism, Family Health, Female, Gene Frequency, Genetic Predisposition to Disease, Haplotypes genetics, Humans, Male, Osteoarthritis genetics, Phosphorylation, Pregnancy, Pregnancy Complications, Prevalence, Protein Folding, Protein Isoforms chemistry, Protein Isoforms metabolism, Protein Processing, Post-Translational genetics, Protein Structure, Tertiary, Substrate Specificity, Amino Acid Substitution, Exons genetics, Factor V genetics, Point Mutation, Polymorphism, Genetic, Protein Isoforms genetics
- Abstract
Recently, a polymorphism was identified in exon 25 of the factor V gene that is possibly a functional candidate for the HR2 haplotype. This haplotype is characterized by a single base substitution named R2 (A4070G) in the B domain of the protein. A mutation (A6755G; 2194Asp-->Gly) located near the C terminus has been hypothesized to influence protein folding and glycosylation, and might be responsible for the shift in factor V isoform (FV1 / FV2) ratio. This study investigated the prevalence of these two factor V HR2 haplotype polymorphisms in a cohort of normal blood donors, patients with osteoarthritis and women with complications during pregnancy, and in families of factor V Leiden individuals. A high allele frequency for the two polymorphisms was found in the blood donor group (6.2% R2, 5.6% A6755G). No significant difference in allele frequency was observed in the clinical groups (obstetric complications and osteoarthritis, 4.1-4.9% for the two polymorphisms) when compared with that of healthy blood donors. We confirm that the factor V A6755G polymorphism shows strong linkage to the R2 allele, although it is not exclusively inherited with the exon 13 A4070G variant and can occur independently.
- Published
- 2001
- Full Text
- View/download PDF
18. Impact of the fibrinolytic enzyme system on prognosis and survival associated with non-small cell lung carcinoma.
- Author
-
Pavey SJ, Hawson GA, and Marsh NA
- Subjects
- Adult, Aged, Aged, 80 and over, Antifibrinolytic Agents metabolism, Biomarkers analysis, Biomarkers blood, Carcinoma, Non-Small-Cell Lung mortality, Female, Fibrin metabolism, Fibrin Fibrinogen Degradation Products metabolism, Fibrinogen metabolism, Humans, Lung Neoplasms blood, Lung Neoplasms mortality, Male, Middle Aged, Multivariate Analysis, Plasminogen Activator Inhibitor 1 metabolism, Prognosis, Reference Values, Risk Factors, Serine Proteinase Inhibitors metabolism, Survival Rate, Carcinoma, Non-Small-Cell Lung blood, Carcinoma, Non-Small-Cell Lung diagnosis, Fibrinolysis physiology, Lung Neoplasms diagnosis
- Abstract
Comprehensive studies of fibrinolysis in non-small cell lung carcinoma have been limited, and assignment of patients to high/low prognosis groups based on arbitrary cut-offs utilizing fibrinolytic measurements is unstandardized. This study was performed in 166 patients to examine the effects of cut-off values determined in three ways. Model 1 assigned patients to one of three equal groups (low, medium, high) based on fibrinolytic measurements made at diagnosis, Model 2 divided patients into low/high groups using median values, and Model 3 grouped according to the parameter being above/below normal range. In model 1, raised plasma fibrinogen, D-dimer and soluble fibrin were positively associated with poorer survival. In model 2, tissue plasminogen activator antigen was additionally related to poorer prognosis. Model 3 identified seven parameters as significantly related to survival, two not identified by the other models becoming significant [plasmin-antiplasmin, tissue plasminogen activator inhibitor-1 (PAI-1) antigen]. Using multivariate analysis, plasma fibrinogen level was the most uniformly significant parameter. Relative risk estimates indicated that raised plasma fibrinogen, soluble fibrin and D-dimer were associated with increased risk of death. Use of the normal/above normal cut-off is recommended to provide the maximum number of significant parameters relating to prognosis, and increased plasma D-dimer, PAI-1 antigen and fibrinogen were most closely related to survival/prognosis.
- Published
- 2001
- Full Text
- View/download PDF
19. DNA technology for the detection of common genetic variants that predispose to thrombophilia.
- Author
-
Pecheniuk NM, Walsh TP, and Marsh NA
- Subjects
- Genetic Variation, Humans, Nucleic Acid Amplification Techniques, Point Mutation, DNA analysis, Genetic Predisposition to Disease, Thrombophilia genetics
- Abstract
With the identification of common single locus point mutations as risk factors for thrombophilia, many DNA testing methodologies have been described for detecting these variations. Traditionally, functional or immunological testing methods have been used to investigate quantitative anticoagulant deficiencies. However, with the emergence of the genetic variations, factor V Leiden, prothrombin 20210 and, to a lesser extent, the methylene tetrahydrofolate reductase (MTHFR677) and factor V HR2 haplotype, traditional testing methodologies have proved to be less useful and instead DNA technology is more commonly employed in diagnostics. This review considers many of the DNA techniques that have proved to be useful in the detection of common genetic variants that predispose to thrombophilia. Techniques involving gel analysis are used to detect the presence or absence of restriction sites, electrophoretic mobility shifts, as in single strand conformation polymorphism or denaturing gradient gel electrophoresis, and product formation in allele-specific amplification. Such techniques may be sensitive, but are unwielding and often need to be validated objectively. In order to overcome some of the limitations of gel analysis, especially when dealing with larger sample numbers, many alternative detection formats, such as closed tube systems, microplates and microarrays (minisequencing, real-time polymerase chain reaction, and oligonucleotide ligation assays) have been developed. In addition, many of the emerging technologies take advantage of colourimetric or fluorescence detection (including energy transfer) that allows qualitative and quantitative interpretation of results. With the large variety of DNA technologies available, the choice of methodology will depend on several factors including cost and the need for speed, simplicity and robustness.
- Published
- 2000
- Full Text
- View/download PDF
20. Multiple analysis of three common genetic alterations associated with thrombophilia.
- Author
-
Pecheniuk NM, Marsh NA, and Walsh TP
- Subjects
- Adenine analysis, Australia, Biotechnology, DNA blood, Factor V genetics, Genetic Variation, Genotype, Guanine analysis, Heterozygote, Humans, Methylenetetrahydrofolate Reductase (NADPH2), Oxidoreductases Acting on CH-NH Group Donors genetics, Point Mutation, Polymerase Chain Reaction, Spectrophotometry, Venous Thrombosis genetics, Thrombophilia genetics
- Abstract
We have previously reported the use of a novel mini-sequencing protocol for detection of the factor V Leiden variant, the first nucleotide change (FNC) technology. This technology is based on a single nucleotide extension of a primer, which is hybridized immediately adjacent to the site of mutation. The extended nucleotide that carries a reporter molecule (fluorescein) has the power to discriminate the genotype at the site of mutation. More recently, the prothrombin 20210 and thermolabile methylene tetrahydrofolate reductase (MTHFR) 677 variants have been identified as possible risk factors associated with thrombophilia. This study describes the use of the FNC technology in a combined assay to detect factor V, prothrombin and MTHFR variants in a population of Australian blood donors, and describes the objective numerical methodology used to determine genotype cut-off values for each genetic variation. Using FNC to test 500 normal blood donors, the incidence of Factor V Leiden was 3.6% (all heterozygous), that of prothrombin 20210 was 2.8% (all heterozygous) and that of MTHFR was 10% (homozygous). The combined FNC technology offers a simple, rapid, automatable DNA-based test for the detection of these three important mutations that are associated with familial thrombophilia.
- Published
- 2000
21. Alterations to the fibrinolytic enzyme system in patients with non-small cell lung carcinoma.
- Author
-
Pavey SJ, Hawson GA, and Marsh NA
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Plasminogen Activator Inhibitor 1 blood, Plasminogen Activators blood, Carcinoma, Non-Small-Cell Lung blood, Fibrinolysis, Lung Neoplasms
- Abstract
Although fibrinolysis has been implicated in the progression and metastasis of lung cancer, no detailed study has been carried out on components measured in samples from both plasma and tumour. This study thus provides the first comprehensive data obtained from 166 patients diagnosed with non-small cell lung carcinoma. Plasma samples were obtained at diagnosis and tumour samples during surgical resection. Appropriate control samples were obtained from normal subjects and patients with chronic obstructive airways disease (plasma) and from organ donors (normal lung tissue). Assays were performed on plasma and tissue extracts for tissue plasminogen activator, urokinase-like activator and plasminogen activator inhibitor (activity and antigen in all cases), together with plasmin-antiplasmin complex, soluble fibrin, D-dimer and thrombin-antithrombin complex. Levels of D-dimer, thrombin-antithrombin complex and plasmin-antiplasmin complex were all significantly higher in plasma from patients, whereas urokinase-like activator activity was reduced. Only two parameters were significantly altered in both the core and periphery of tumour tissue: levels of D-dimer were increased and tissue-type plasminogen activator activity was reduced. Interestingly, significant differences in levels of other fibrinolytic parameters were detected in the core and periphery of tumours. Significant activation of fibrinolysis was indicated in patients, although the origin of this could not be related consistently to changes in levels of plasminogen activator and inhibitor.
- Published
- 1999
- Full Text
- View/download PDF
22. New insights into nitric oxide and coronary circulation.
- Author
-
Gattullo D, Pagliaro P, Marsh NA, and Losano G
- Subjects
- Animals, Humans, Coronary Circulation physiology, Nitric Oxide physiology
- Abstract
Since its discovery over 20 years ago as an intercellular messenger, nitric oxide (NO), has been extensively studied with regard to its involvement in the control of the circulation and, more recently, in the prevention of atherosclerosis. The importance of NO in coronary blood flow control has also been recognized. NO-independent vasodilation causes increased shear stress within the blood vessel which, in turn, stimulates endothelial NO synthase activation, NO release and prolongation of vasodilation. Reactive hyperemia, myogenic vasodilation and vasodilator effects of acetylcholine and bradykinin are all mediated by NO. Ischemic preconditioning, which protects the myocardium from cellular damage and arrhythmias, is itself linked with NO and both the first and second windows of protection may be due to NO release. Exercise increases NO synthesis via increases in shear stress and pulse pressure and so it is likely that NO is an important blood flow regulatory mechanism in exercise. This phenomenon may account for the beneficial effects of exercise seen in atherosclerotic individuals. Whilst NO plays a protective role in preventing atherosclerosis via superoxide anion scavenging, risk factors such as hypercholesterolemia reduce NO release leading the way for endothelial dysfunction and atherosclerotic lesions. Exercise reverses this process by stimulating NO synthesis and release. Other factors impacting on the activity of NO include estrogens, endothelins, adrenomedullin and adenosine, the last appearing to be a compensatory pathway for coronary control in the presence of NO inhibition. These studies reinforce the pivotal role played by the substance in the control of coronary circulation.
- Published
- 1999
- Full Text
- View/download PDF
23. Use of snake venom fractions in the coagulation laboratory.
- Author
-
Marsh NA
- Subjects
- Animals, Biological Assay, Clinical Laboratory Techniques, Humans, Anticoagulants, Coagulants, Hemostasis, Snake Venoms
- Abstract
Snake venom toxins are now regularly used in the coagulation laboratory for assaying haemostatic parameters and as coagulation reagents. Snake venom thrombin-like enzymes (SVTLE) are used for fibrinogen and fibrinogen breakdown product assay as well as detecting dysfibrinogenaemias. Significantly, because SVTLE are not inhibited by heparin, they can be used for defibrinating samples that contain the anticoagulant before assay of haemostatic variables. Prothrombin activators are found in many snake venoms and are used in prothrombin assays, for studying dysprothrombinaemias and preparing meizothrombin and non-enzymic prothrombin. Russell's viper (Daboia russelli) venom (RVV) contains a number of compounds useful in the assay of factors V, VII, X, platelet factor 3 and lupus anticoagulants. Activators from the taipan, Australian brown snake and saw-scaled viper have been used to assay lupus anticoagulants. Protein C and activated protein C resistance can be measured by means of RVV and Protac, a fast acting inhibitor from Southern copperhead snake venom and von Willebrand factor can be studied with Botrocetin from Bothrops jararaca venom. Finally, phospholipase A2 enzymes and the disintegrins, a family of Arg-Gly-Asp (RGD)-containing proteins found in snake venoms, show great potential for the study of haemostasis including, notably, platelet glycoprotein receptors GPIIb/IIIa and Ib.
- Published
- 1998
- Full Text
- View/download PDF
24. Use of first nucleotide change technology to determine the frequency of factor V Leiden in a population of Australian blood donors.
- Author
-
Pecheniuk NM, Marsh NA, Walsh TP, and Dale JL
- Subjects
- Australia epidemiology, Genetic Variation, Humans, Mutation, Prevalence, Risk Factors, Thrombophilia epidemiology, Adenine analysis, Blood Donors, Factor V metabolism, Genetic Testing methods, Guanine analysis, Thrombophilia blood
- Abstract
Activated protein C resistance (APCR), the most common risk factor for venous thrombosis, is the result of a G to A base substitution at nucleotide 1691 (R506Q) in the factor V gene. Current techniques to detect the factor V Leiden mutation, such as determination of restriction length polymorphisms, do not have the capacity to screen large numbers of samples in a rapid, cost-effective test. The aim of this study was to apply the first nucleotide change (FNC) technology, to the detection of the factor V Leiden mutation. After preliminary amplification of genomic DNA by polymerase chain reaction (PCR), an allele-specific primer was hybridised to the PCR product and extended using fluorescent terminating dideoxynucleotides which were detected by colorimetric assay. Using this ELISA-based assay, the prevalence of the factor V Leiden mutation was determined in an Australian blood donor population (n = 500). A total of 18 heterozygotes were identified (3.6%) and all of these were confirmed with conventional MnlI restriction digest. No homozygotes for the variant allele were detected. We conclude from this study that the frequency of 3.6% is compatible with others published for Caucasian populations. In addition, the FNC technology shows promise as the basis for a rapid, automated DNA based test for factor V Leiden.
- Published
- 1997
- Full Text
- View/download PDF
25. Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin.
- Author
-
Ray MJ and Marsh NA
- Subjects
- Adult, Double-Blind Method, Enzyme-Linked Immunosorbent Assay, Fibrin Fibrinogen Degradation Products metabolism, Fibrinolysis, Hemodilution, Humans, Postoperative Hemorrhage etiology, Thrombin metabolism, Tissue Plasminogen Activator metabolism, Aprotinin therapeutic use, Blood Loss, Surgical prevention & control, Cardiopulmonary Bypass adverse effects, Fibrinolysin antagonists & inhibitors, Postoperative Hemorrhage prevention & control, Serine Proteinase Inhibitors therapeutic use
- Abstract
The effectiveness and mechanism of aprotinin reduced bleeding after cardiopulmonary bypass surgery was studied in a double blind randomised study of 106 patients undergoing valve replacement surgery. Aprotinin therapy was associated with significant reduction in perioperative bleeding and postoperative blood transfusion requirements. Although initially tissue plasminogen activator (t-PA) activity was lower in the aprotinin than placebo group, as surgery proceeded this difference was reversed due to less plasminogen activator inhibitor-1 release in the aprotinin group. This indicates that aprotinin-mediated suppression of fibrinolysis as demonstrated by reduced D-dimer concentration was not related to t-PA. Furthermore, similar perioperative reduction of plasminogen levels in aprotinin and placebo groups indicated a similar degree of conversion of plasminogen to plasmin. However, less plasmin bound with alpha 2-antiplasmin in the plasma in the aprotinin group as it was already complexed with aprotinin where it remained protected from the natural inhibitor on the intact fibrin surface. The reduced fibrinolytic activity of the aprotinin group was thus brought about by the complexing of aprotinin with the plasmin which was bound to the fibrin surface.
- Published
- 1997
26. A brief review of studies evaluating the adverse effects of aprotinin therapy in aortocoronary bypass surgery.
- Author
-
Ray MJ, Marsh NA, and Mengerson K
- Subjects
- Controlled Clinical Trials as Topic, Humans, Treatment Outcome, Aprotinin adverse effects, Coronary Artery Bypass, Hemostatics adverse effects
- Published
- 1997
27. Isolation and partial characterization of a prothrombin-activating enzyme from the venom of the Australian rough-scaled snake (Tropidechis carinatus).
- Author
-
Marsh NA, Fyffe TL, and Bennett EA
- Subjects
- Animals, Australia, Calcium, Chromatography, Gel, Coagulants chemistry, Electrophoresis, Polyacrylamide Gel, Factor Xa, Humans, Phospholipids, Snake Venoms enzymology, Thromboplastin chemistry, Blood Coagulation drug effects, Coagulants isolation & purification, Snake Venoms chemistry, Snake Venoms pharmacology, Thromboplastin isolation & purification, Thromboplastin pharmacology
- Abstract
A prothrombin activator from the venom of Tropidechis carinatus has been isolated by means of gel filtration and benzamidine-based affinity chromatography, a novel use of the latter technique. Two bands possessing prothrombinase activity were obtained from the affinity chromatography procedure and designated A1 and A2. The bulk of the enzyme activity was recovered in peak A2 which represented 27-31% of the starting activity and a 14-16-fold purification. The venom contained, in total, around 5% by weight of the two isoforms of the prothrombin activator. The two fractions were electrophoretically similar on polyacrylamide electrophoresis, migrating with a mol. wt of 64,500 under native conditions and as a single band of 41,500 under reducing conditions. The prothrombinase was dependent on factor Va, phospholipid and calcium ions for its activity and is, thus, a member of the type II class of prothrombinases requiring such co-factors. The enzyme did not possess any phospholipase activity nor did it cleave the substrates N-alpha-benzoyl-L-arginine-p-nitroanilide (BAPNA), N-benzoyl-L-tyrosine ethyl ester (BTEE), azocollagen or azocasein, indicating a lack of amidolytic, esterolytic and broad-spectrum protease activity.
- Published
- 1997
- Full Text
- View/download PDF
28. Preoperative platelet dysfunction increases the benefit of aprotinin in cardiopulmonary bypass.
- Author
-
Ray MJ, Marsh NA, Just SJ, Perrin EJ, O'Brien MF, and Hawson GA
- Subjects
- Blood Transfusion, Double-Blind Method, Female, Flow Cytometry, Heart Valve Prosthesis, Humans, Male, Middle Aged, Platelet Activation physiology, Platelet Aggregation physiology, Platelet Function Tests, von Willebrand Factor metabolism, Aprotinin therapeutic use, Blood Loss, Surgical prevention & control, Blood Platelets physiology, Cardiopulmonary Bypass, Serine Proteinase Inhibitors therapeutic use
- Abstract
Background: This study was designed to determine the benefit of aprotinin therapy in reducing bleeding during and after cardiopulmonary bypass in patients with preoperative platelet dysfunction. Platelet function involvement in the mechanism by which aprotinin acts was also investigated., Methods: In a double-blind, randomized study, patients received high-dose aprotinin (n = 54) or placebo (n = 52). Whole blood aggregation was measured preoperatively. Platelet function and activation in both groups were assessed intraoperatively and postoperatively at five times., Results: Aprotinin significantly reduced perioperative bleeding and postoperative blood transfusion. Placebo-treated patients with reduced preoperative platelet aggregation bled more postoperatively, but aprotinin reduced the bleeding in patients with normal or reduced platelet function to similar levels. Any cardiopulmonary bypass-induced changes in platelet aggregation, platelet activation as measured by P-selectin expression, and von Willebrand factor antigen and function were similar in aprotinin-treated and placebo-treated groups., Conclusions: The mechanism by which aprotinin reduced bleeding was independent of any effect on platelet function. However, aprotinin produced a greater reduction in bleeding among patients whose condition was hemostatically compromised by preoperative platelet dysfunction.
- Published
- 1997
- Full Text
- View/download PDF
29. Changes in plasminogen activator inhibitor-1 levels in non-small cell lung cancer.
- Author
-
Pavey SJ, Marsh NA, Ray MJ, Butler D, Dare AJ, and Hawson GA
- Subjects
- Actuarial Analysis, Adult, Aged, Aged, 80 and over, Carcinoma, Non-Small-Cell Lung classification, Carcinoma, Non-Small-Cell Lung mortality, Carcinoma, Non-Small-Cell Lung pathology, Female, Fibrinolysis, Humans, Lung Neoplasms mortality, Lung Neoplasms pathology, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Staging, Prognosis, Receptors, Cell Surface blood, Receptors, Urokinase Plasminogen Activator, Survival Analysis, Urokinase-Type Plasminogen Activator blood, Carcinoma, Non-Small-Cell Lung chemistry, Lung Neoplasms chemistry, Neoplasm Proteins analysis, Plasminogen Activator Inhibitor 1 analysis
- Abstract
Increased urokinase plasminogen activator (uPA) levels are increased in a number of malignancies and have been correlated with decreased disease-free interval and decreased overall survival. We have, therefore, examined components of this plasminogen activating system in patients with Non-Small Cell Lung Cancer (NSCLC). Levels of uPA, urokinase-plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) were measured semiquantitatively in paraffin sections of tumours from 147 patients with NSCLC. Immunohistochemically stained sections of tumour were allocated a score for stain intensity and results correlated to: survival; tumour stage(T); nodal stage(N); stage grouping (I to IIIb), survival status and sex. Increased levels of PAI-1 were associated with a decreased survival in squamous cell carcinoma (SCC) X2 = 5.72, p = 0.017 (n = 74). There was a significant positive relationship between PAI-1 levels and N-stage (p = < 0.05), presence of nodal metastases (p = < 0.05), stage grouping (p = < 0.01) and extent of disease (p = < 0.05) in the total group and the SCC subgroup, but not adenocarcinoma. There was a significant positive relationship between PAI-1 levels and T-stage (p = < 0.05) in the total group, and survival status (p = < 0.05) in the SCC subgroup alone. uPA and uPAR levels were not significantly associated with tumour staging or survival. We conclude that increased PAI-1 antigen levels may be associated with a decreased survival in patients with SCC.
- Published
- 1996
30. Practical applications of snake venom toxins in haemostasis.
- Author
-
Marsh NA and Fyffe TL
- Subjects
- Animals, Humans, Indicators and Reagents, Snake Venoms pharmacology, Hemostasis drug effects, Snake Venoms therapeutic use
- Abstract
Snake venom toxins have an established role in the coagulation laboratory for the assay of haemostatic parameters and a potential role for therapeutic treatment of thrombotic disorders. In the laboratory, snake venom thrombin-like enzymes (SVTLEs) are used for the assay of fibrinogen and detection of fibrinogen breakdown products and dysfibrinogenaemias. Importantly, because SVTLEs are not inhibited by heparin, they can be used for assaying antithrombin III and other parameters in samples which contain heparin. Prothrombin activators occur in many snake venoms and these have become established in the assay of prothrombin, in the study of dysprothrombinaemias and in the preparation of meizothrombin and non enzymic forms of prothrombin. Russell's viper (Daboia russelli) venom contains a number of useful compounds including toxins which can be used to assay blood clotting factors V, VII, X, platelet factor 3 and lupus anticoagulants (LA). More recently, activators from the taipan, Australian brown snake and saw-scaled viper have been used to assay LA. Proteins C and S can be measured by means of protac, a fast acting inhibitor from Southern copperhead snake venom and von Willebrand factor can be studied with botrocetin from Bothrops jararaca venom. The disintegrins, a large family of Arg-Gly-Asp (RGD)-containing proteins found in snake venoms, show great potential for the study of platelet glycoprotein receptors, notably, GPIIb/IIIa and Ib, and in the treatment of arterial thrombotic disease. Established SVTLEs used in clinical practice include ancrod and defibrase although success with these agents has been limited. A further group of enzymes under consideration as thrombolytic agents are the fibrinogenases.
- Published
- 1996
31. The heart rate after inhibition of nitric oxide release in the anaesthetized dog.
- Author
-
Pagliaro P, Dalla Valle R, Gattullo D, Merletti A, and Marsh NA
- Subjects
- Anesthesia, General, Animals, Blood Pressure drug effects, Coronary Circulation drug effects, Depression, Chemical, Dogs, Nitric Oxide metabolism, Nitric Oxide Synthase antagonists & inhibitors, Pressoreceptors drug effects, Sinoatrial Node drug effects, Sympathetic Nervous System drug effects, Sympathetic Nervous System physiology, Vagotomy, Enzyme Inhibitors pharmacology, Heart Rate drug effects, Nitric Oxide antagonists & inhibitors, Nitroarginine pharmacology
- Abstract
1. The effect of nitric oxide (NO) inhibition on heart rate was studied in anaesthetized vagotomized dogs. 2. The effect of changes of baroreceptor stimulation was prevented using an arterial pressure reservoir. 3. After NO-inhibitor (Nitro-L-arginine), heart rate decreased by 8% in spite of an unchanged pressure. 4. When upstream pressure was increased by constriction of the descending aorta, heart rate decreased by 4% before and after inhibition. Owing to the vagotomy this decrease was attributed to a sympathetic tone reduction following baroreceptor stimulation. 5. The results show that NO-inhibition reduces heart rate independently of an increased baroreceptor stimulation and does not reduce the basal sympathetic control on the sinus-atrial node.
- Published
- 1996
- Full Text
- View/download PDF
32. Isolation and characterisation of two haemorrhagic proteins (HTa and HTb) from the venom of Bitis gabonica (Gaboon viper).
- Author
-
Marsh NA, Fyffe TL, and Bennett EA
- Subjects
- Animals, Cells, Cultured, Endothelium, Vascular drug effects, Hemorrhage chemically induced, Male, Metalloendopeptidases chemistry, Metalloendopeptidases pharmacology, Mice, Mice, Inbred BALB C, Viper Venoms enzymology, Viper Venoms pharmacology, Viperidae, Metalloendopeptidases isolation & purification, Viper Venoms chemistry
- Abstract
Two distinct haemorrhagic proteinases, HTa and HTb, were isolated from the venom of Bitis gabonica by gel filtration and ion-exchange chromatography with native mol. wts of 180,000 and 111,000, respectively. After reduction with dithiothreitol, smaller mol. wts of 77,600 and 69,200 were recorded for HTa and HTb, suggesting that under native conditions the haemorrhagins exist as dimeric molecules. Both toxins possessed caseinolytic and collagenase activity although HTa was 15-36 times more potent than HTb with respect to collagenase activity. No zinc could be detected in the toxins; however, dialysis against ethylenediamine tetracetic acid (EDTA) reduced caseinolytic activity, suggesting the dependence of the latter on other metal ions. HTa and HTb had a marked effect on the intrinsic cascade coagulation mechanism (factors IX, XI and XII) but no effect on the final common coagulation pathway (factor X and prothrombin). Light and electron microscopical studies demonstrated that both HTa and HTb caused organ-specific lesions, with the lungs, diaphragm and body wall muscle being most affected. HTa caused widespread haemorrhage whilst HTb caused discrete focal lesions near the site of injection and elsewhere. However, both toxins appeared to cause capillary rupture by the separation of cells from one another and both caused cell detachment and cell death of bovine endothelial cells cultured in vitro, consonant with the massive disruption of capillaries seen in vivo.
- Published
- 1995
- Full Text
- View/download PDF
33. Heart rate decrease after inhibition of nitric oxide release in the anaesthetized dog.
- Author
-
Pagliaro P, Gattullo D, Merletti A, Losano G, and Marsh NA
- Subjects
- Adenosine metabolism, Anesthesia, Animals, Arginine pharmacology, Baroreflex drug effects, Blood Pressure drug effects, Bradycardia chemically induced, Bradycardia physiopathology, Coronary Circulation drug effects, Dogs, Myocardium metabolism, Nitric Oxide Synthase, Nitroarginine, Pressoreceptors physiology, Vagotomy, Amino Acid Oxidoreductases antagonists & inhibitors, Arginine analogs & derivatives, Dipyridamole pharmacology, Heart Rate drug effects, Nitric Oxide physiology
- Abstract
In 5 anaesthetized vagotomized dogs the administration of an inhibitor of the synthesis of nitric oxide (NO) was seen to reduce the heart rate, although the arterial pressure was prevented from increasing. Such a finding suggests that the inhibition of nitric oxide release can produce bradycardia without the involvement of baroreceptor reflexes. Since NO inhibition is known to increase the concentration of adenosine in the myocardium, in 3 additional dogs, dipyridamole, which also potentiates the effect of adenosine, was infused: a reduction in heart rate was observed also in these animals. In both groups of animals, before and after the administration of the relevant compound, the increase in ABP obtained with aortic constriction caused the same reduction in heart rate, which which was attributed to a reduction of the basal sympathetic discharge, which was shown not to be affected by NO inhibition. It is concluded that NO inhibition can cause bradycardia without the intervention of any nervous mechanism but with the possible intervention of an increase in myocardial adenosine concentration.
- Published
- 1995
34. Control of coronary blood flow by endothelial release of nitric oxide.
- Author
-
Losano G, Pagliaro P, Gattullo D, and Marsh NA
- Subjects
- Animals, Vasodilation physiology, Coronary Circulation physiology, Endothelium, Vascular physiology, Nitric Oxide physiology
- Abstract
1. Nitric oxide (NO) is released from vascular endothelium following conversion of L-arginine to L-citrulline by calcium-calmodulin-dependent 'constitutive' NO-synthase. 2. Nitric oxide release occurs under basal conditions, in response to chemical stimuli (acetylcholine, bradykinin, thrombin, prostacyclin, serotonin, etc.) and in response to changes in shear stress (effects of blood velocity on vascular endothelium). 3. Analogues of L-arginine inhibit NO and are widely used to study the effects of NO on the cardiovascular system: in intact animals, these inhibitors cause vasoconstriction, leading to an increase in arterial blood pressure (ABP) and bradycardia. 4. Bradycardia induced by NO inhibitors is due, in part, to baroreceptor activity following the increase in ABP and in part to a direct effect on the sino-atrial node. 5. In the intact animals and isolated perfused heart, NO inhibitors cause coronary vasoconstriction and hence a reduction in basal coronary flow. This effect, however, is not seen in isolated coronary vessels. 6. From experiments in which ABP did not change, NO does not appear to have an important role in regulating coronary vasomotor tone under basal conditions. 7. Nitric oxide appears to be involved in the duration of reactive hyperaemia following coronary vascular occlusion but is not involved to any significant extent in the peak amplitude of hyperaemia. 8. Responses to vasodilator stimuli which do not involve NO in the initiation of the vasodilation may be prolonged by the effect of increased blood flow (shear stress) which releases NO and potentiates hyperaemia.
- Published
- 1994
- Full Text
- View/download PDF
35. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass.
- Author
-
Ray MJ, Marsh NA, and Hawson GA
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Fibrin metabolism, Fibrin Fibrinogen Degradation Products metabolism, Fibrinogen metabolism, Hemodilution, Hemorrhage etiology, Humans, Male, Middle Aged, Plasminogen metabolism, Plasminogen Activator Inhibitor 1 metabolism, Platelet Aggregation, Tissue Plasminogen Activator metabolism, alpha-2-Antiplasmin metabolism, Blood Platelets physiology, Cardiopulmonary Bypass adverse effects, Fibrinolysis, Hemorrhage blood
- Abstract
In order to study the effects of cardiopulmonary bypass (CPB) on fibrinolysis and platelet function and the possible relationship of these effects on post-operative blood loss, 127 patients undergoing CPB were examined. There was a significant reduction in the median levels of fibrinogen, plasminogen, alpha 2-antiplasmin, fibrinolytic potential and platelet aggregation during CPB (P < or = 0.001). Median levels of soluble fibrin, fibrinogen degradation products, D-dimer and PAI-1 were increased, while the level of t-PA activity remained constant. Post-CPB levels of fibrinogen and plasminogen correlated negatively with blood loss (P = 0.003 and P < 0.001, respectively) and interestingly, lower levels of alpha 2-antiplasmin and higher levels of t-PA activity before CPB were associated with greater blood loss after CPB (P < 0.001 and P = 0.004, respectively). Better pre-CPB platelet function correlated with lower levels of D-dimer before and after CPB. As expected, haemodilution had a significant effect on fibrinolytic and coagulation parameters post-CPB; the greater the haemodilution, the more the concentration of fibrinogen, plasminogen and alpha 2-antiplasmin fell post-CPB and the greater the blood loss. The increase in PAI-1 levels intra-CPB appeared to result in mean t-PA activity remaining unchanged 1 h post-CPB. Post-CPB increases in soluble fibrin were paralleled by increases in fibrinogen degradation products and D-dimer, suggesting that intra-operative contact activation is related to activation of the fibrinolytic system. The present findings indicate the greater the fibrinolytic activation, the greater the post-CPB blood loss.
- Published
- 1994
- Full Text
- View/download PDF
36. Snake venoms affecting the haemostatic mechanism--a consideration of their mechanisms, practical applications and biological significance.
- Author
-
Marsh NA
- Subjects
- Animals, Blood Coagulation, Fibrinolysin metabolism, Fibrinolysis, Hemorrhage, Humans, Platelet Aggregation, Snake Venoms therapeutic use, Hemostasis, Snake Venoms pharmacology
- Abstract
Snake venoms contain a rich variety of factors affecting the haemostatic mechanism which can be broadly classified as possessing coagulatant, anticoagulant and haemorrhagic activity. Coagulant enzymes include activators of blood coagulation factors II (prothrombin), V and X; anticoagulants include protein C activators, inhibitors of prothrombin complex formation and fibrinogenases which can be further classified according to their specificity for the alpha-, beta- and gamma-chains of fibrinogen. Intermediate between true coagulants and true anticoagulants are the thrombin-like enzymes which bring about clotting in vitro but defibrination (anticoagulation) in vivo. Snake venoms also affect platelets either by inducing or inhibiting platelet aggregation and cause haemorrhage via an action on platelets or via proteolysis of the blood vessel wall. Haemorrhagins also include inter alia, the alpha-fibrinogenases. This rich diversity of snake venom components affecting haemostasis has enabled a range of practical applications to be established including therapeutic anticogulation with thrombin-like enzymes (Ancrod and Defibrase) and laboratory tests for individual haemostatic factors (protein C, prothrombin, factor X and lupus anticoagulant). This broad spectrum of materials in snake venoms suggests some evolutionary advantage to the venom producer, not only for dispatching prey but as agents which 'spread' the venom toxins throughout the body and initiate digestion.
- Published
- 1994
37. Accidental envenoming by a Gaboon viper (Bitis gabonica): the haemostatic disturbances observed and investigation of in vitro haemostatic properties of whole venom.
- Author
-
McNally T, Conway GS, Jackson L, Theakston RD, Marsh NA, Warrell DA, Young L, Mackie IJ, and Machin SJ
- Subjects
- Adult, Antivenins therapeutic use, Blood Coagulation drug effects, Humans, Male, Plasma, Snake Bites therapy, Substrate Specificity, Thrombin Time, Hemostasis, Snake Bites blood, Viper Venoms pharmacology
- Abstract
We report the successful treatment of envenoming by the Gaboon viper (Bitis gabonica) and include results of in vitro investigations of the haemostatic properties of the whole venom. The patient was admitted to casualty soon after the bite with chest tightness, dizziness, nausea and swelling at the site of the bite and was treated immediately with polyspecific antivenom, hydrocortisone, chlorpheniramine and antibiotics. Results of haemostatic investigations were essentially normal on admission but on day 3 the thrombin time became prolonged and was associated with significant hypofibrinogenaemia and elevated D-dimers. Factors V and VIII, antithrombin III and protein C levels and platelet number were not significantly reduced. The haemostatic disturbances persisted for more than 24 h despite treatment with blood products (16 units of cryoprecipitate, 2 units of fresh frozen plasma and 6 units of platelet concentrate). Resolution of the abnormalities occurred only after administration of a further dose of antivenom. The period of hypofibrinogenaemia occurred at a time when venom antigen was undetectable in plasma by enzyme-linked immunosorbent assay. Studies in vitro with whole venom and a panel of amidolytic substrates commonly employed for measurement of haemostatic proteins revealed significant activity of venom with substrates sensitive to kallikrein and plasmin. The venom inhibited washed platelet aggregation induced by collagen, thrombin, arachidonic acid and the calcium ionophore A23187 in a dose-dependent manner.
- Published
- 1993
- Full Text
- View/download PDF
38. In vivo and in vitro effects of low molecular weight heparan sulphate on the human fibrinolytic enzyme system.
- Author
-
Marsh NA and Born GV
- Subjects
- Adenosine Diphosphate pharmacology, Adult, Collagen pharmacology, Humans, Molecular Weight, Plasminogen Activators metabolism, Platelet Aggregation drug effects, Tissue Plasminogen Activator metabolism, Fibrinolysis drug effects, Heparitin Sulfate pharmacology
- Abstract
The aim of this study was to evaluate the effects of a preparation of low molecular weight heparan sulphate (LMW-HS) on the fibrinolytic system. Twenty-five healthy volunteers received LMW-HS by mouth in three separate experiments. In the first experiment, 10 volunteers received either 80 mg LMW-HS or placebo in a single-blind cross-over study; blood samples were taken before and 1, 2, 3 and 6 h after treatment. LMW-HS caused an increase in global fibrinolysis, the effect being greatest after 2-3 h and disappearing by 6 h. However, neither plasminogen activator activity nor tissue-type plasminogen activator (tPA) antigen levels were changed. In the second experiment, daily doses of 80 mg LMW-HS were administered to 10 volunteers for 7 days; this regimen did not produce a statistically significant increase in fibrinolytic activity for the whole group although some individuals did respond markedly. In the third experiment, 160 mg LMW-HS administered to five volunteers did not affect ADP- and collagen-induced platelet aggregation. In vitro, LMW-HS added to plasma at concentrations of 20 and 30 micrograms/ml, brought about a significant increase in apparent plasminogen activator activity. These results suggest that the increased fibrinolytic activity seen after LMW-HS is due to the recruitment of additional amounts of tPA in the ex vivo test system. LMW-HS had no effect on plasminogen activator inhibitor.
- Published
- 1991
- Full Text
- View/download PDF
39. The haemodynamic effect of Bitis nasicornis (rhinoceros horned viper) venom.
- Author
-
Alloatti G, Gattullo D, Dalla Valle R, Marsh NA, Pagliaro P, and Vono P
- Subjects
- Animals, Blood Pressure drug effects, Cardiac Output drug effects, Dogs, Electric Stimulation, Heart Rate drug effects, Hemodynamics drug effects, Viper Venoms pharmacology
- Abstract
1. Intravenous venom (0.0625 mg/kg) in the dog caused an immediate increase in coronary blood flow due to a fall in coronary vascular resistance (CVR). 2. Subsequently, total peripheral resistance (TPR) fell causing a significant reduction in aortic blood pressure (ABP). 3. CVR and TPR returned to normal after 20 min but ABP did not recover completely. 4. The failure of ABP to recover was due to decreased stroke volume and cardiac output (CO). 5. Animals died after four doubling doses of venom following irreversible reductions in CO, ABP and coronary flow.
- Published
- 1991
- Full Text
- View/download PDF
40. Acidotic effect of gaboon viper (Bitis gabonica) venom in the urethane-anaesthetized rat.
- Author
-
Gattullo D, Hyslop S, Marsh NA, Pagliaro P, and Vono P
- Subjects
- Acid-Base Equilibrium drug effects, Anesthesia, Animals, Bicarbonates blood, Carbon Dioxide blood, Electrocardiography, Electrodes, In Vitro Techniques, Oxygen Consumption drug effects, Rats, Rats, Inbred Strains, Urethane, Acidosis chemically induced, Viper Venoms toxicity
- Abstract
1. Intravenous venom (4 mg/kg) caused a non-compensated metabolic acidosis. 2. Bicarbonate concentration, base excess, standard base excess and pH all fell dramatically. 3. A respiratory impairment occurred characterized by pulmonary oedema and a fall in arterial pO2. 4. Acidosis occurred soon after venom when pO2 was still normal, indicating that changes in tissue metabolism contributed to the acidosis independently of reduced oxygen availability.
- Published
- 1991
- Full Text
- View/download PDF
41. Comparison of the physiological effects in rabbits of gaboon viper (Bitis gabonica) venoms from different sources.
- Author
-
Hyslop S and Marsh NA
- Subjects
- Africa, Eastern, Africa, Western, Animals, Blood Glucose metabolism, Blood Pressure drug effects, Carbon Dioxide blood, Electrocardiography drug effects, Female, Heart Rate drug effects, Hematocrit, Hemodynamics drug effects, Hemorrhage chemically induced, Hemorrhage pathology, Hydrogen-Ion Concentration, Lactates blood, Male, Oxygen blood, Rabbits, Respiration drug effects, Viper Venoms toxicity
- Abstract
The cardiovascular, respiratory and metabolic effects of B. gabonica venoms obtained from specimens originating from Ghana, Togo, Nigeria, Uganda and Tanzania were examined in anaesthetized rabbits. Intravenous injection of all venoms (0.125-2.0 mg/kg) induced hypotension. Nigeria venom was the least potent in this respect. Following doses of all venoms there was a brief bradycardia and a transient increase in respiratory rate and depth. At high doses (greater than or equal to 1.0 mg/kg), all venoms induced severe ST depression and T wave inversion. In addition, Togo venom, and to a lesser extent Tanzania and Ghana venoms, were potent in inducing extrasystoles. None of the venoms produced any significant changes in haematocrit, plasma proteins or arterial blood gas and pH levels. All venoms increased blood glucose and lactate levels by 1.3-2.1 fold and 2.2-4.0 fold respectively while the respiratory quotient remained unchanged. Togo venom was significantly (P less than 0.05) more lethal than the other venoms. The pattern of haemorrhage observed at post-mortem was the same for all venoms with the heart, ureters, adrenals, kidneys, lungs, stomach and intestines being the most affected. When combined on a subspecies basis, the results suggest that there are no significant differences in the physiological effects of venoms representing B. g. rhinoceros (West African gaboon viper) and B. g. gabonica (East African gaboon viper).
- Published
- 1991
- Full Text
- View/download PDF
42. The mechanical and electrical effects of rhinoceros viper (Bitis nasicornis) venom on the isolated perfused guinea pig heart and atrial preparations.
- Author
-
Alloatti G, Gattullo D, Marsh NA, Pagliaro P, and Vono P
- Subjects
- Action Potentials, Animals, Atrial Function, Coronary Circulation, Guinea Pigs, Heart Block etiology, Heart Rate, In Vitro Techniques, Myocardial Contraction, Ranitidine pharmacology, Heart physiology, Viper Venoms toxicity
- Abstract
The mechanical and electrical effects of the venom of Bitis nasicornis were studied on the guinea-pig Langendorff and left atrial myocardium preparations. While Langendorff preparations were treated with individual doses of 0.1, 0.6 and 1.4 mg, isolated left atria were treated using concentrations of 2.0, 20 and 200 micrograms/ml of venom in the perfusion solution. In the Langendorff preparation, transient increases in left ventricular systolic pressure (LVSP) and heart rate (HR) were seen after 0.1 mg of venom. When 0.6 mg of venom was given, the increases were followed by decreases, while 1.4 mg doses simply induced decreases in LVSP and HR. After both 0.6 and 1.4 mg doses the decreases were accompanied by increases in left ventricular diastolic pressure. In addition to these mechanical effects, transient increases in HR with atrio-ventricular blocks, ventricular extrasystoles and tachycardia were observed after each dose. In the left atrium the 2 micrograms/ml venom concentration produced an increase, followed by a decrease, in the maximum tension developed, which was only seen to decrease with higher concentrations of 20 and 200 micrograms/ml of venom. A dose dependent significant reduction in the action potential duration was observed for the doses of 0.6 and 1.4 mg in the ventricle and for all three concentrations in the atrium.
- Published
- 1991
- Full Text
- View/download PDF
43. The effect of heparin and other glycosaminoglycans on levels of tissue plasminogen activator and plasminogen activator inhibitor in cultured human umbilical vein endothelial cells.
- Author
-
Marsh NA, Minter AJ, and Chesterman CN
- Subjects
- Cell Division drug effects, Cells, Cultured drug effects, Chondroitin Sulfates pharmacology, Dermatan Sulfate pharmacology, Heparin, Low-Molecular-Weight pharmacology, Heparitin Sulfate pharmacology, Humans, Umbilical Veins, Endothelium, Vascular drug effects, Glycosaminoglycans pharmacology, Heparin pharmacology, Plasminogen Inactivators analysis, Tissue Plasminogen Activator analysis
- Abstract
Human umbilical vein endothelial cells (HUVEC) were cultured in the presence of various glycosaminoglycans and the intracellular levels of tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) measured by ELISA. 10 IU/ml heparin (90 micrograms/ml) brought about a significant (20-fold) increase in intracellular tPA levels over the 6-day culture period; intracellular PAI-1 levels were significantly decreased (by 60-70%) and culture growth rate promoted. The final cell density of heparin-containing cultures was 1.7 to 2.3 times greater than that of control cultures. Low molecular weight heparin (First International Standard) had similar effects but was less potent than unfractionated heparin. Chondroitin sulphate and heparan sulphate had no effect on tPA and PAI-1 levels but dermatan sulphate reduced PAI-1 significantly. The changes observed following exposure of HUVEC to heparin are consonant with the view that glycosaminoglycans may affect endothelial production of fibrinolytic components.
- Published
- 1990
44. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
- Author
-
Fischer AM, Merton RE, Marsh NA, Williams S, Gaffney PJ, Barrowcliffe TW, and Thomas DP
- Subjects
- Factor X antagonists & inhibitors, Heparin administration & dosage, Humans, Injections, Subcutaneous, Partial Thromboplastin Time, Pentosan Sulfuric Polyester administration & dosage, Blood Coagulation drug effects, Heparin pharmacology, Pentosan Sulfuric Polyester pharmacology, Polysaccharides pharmacology
- Abstract
A comparison has been made between the effects of pentosan polysulphate (SP54) and mucosal heparin following subcutaneous injection in man. Unlike heparin, pentosan polysulphate has relatively little effect in vivo as measured by anti-factor Xa clotting assay and none by an anti-Xa amidolytic assay (S-2222). However, pentosan polysulphate is at least as potent as heparin on a weight basis in producing activation of lipoprotein lipase, shortening of the euglobulin clot lysis time and impairing the generation of factor Xa. Our data indicate that pentosan polysulphate has more marked effects in vivo than in vitro, that the action of the drug on clotting is mediated mainly via an At III-independent pathway, and that its effects are not confined to the coagulation system.
- Published
- 1982
45. Langendorff and the perfused heart [proceedings].
- Author
-
Marsh NA
- Subjects
- Animals, History, 19th Century, In Vitro Techniques, Perfusion instrumentation, Physiology instrumentation, Heart physiology, Physiology history
- Published
- 1979
46. The Gaboon viper (Bitis gabonica): its biology, venom components and toxinology.
- Author
-
Marsh NA and Whaler BC
- Subjects
- Animals, Hemodynamics drug effects, Hemorrhage etiology, Humans, Phospholipases A analysis, Phospholipases A2, Snake Bites therapy, Thrombin analysis, Viper Venoms analysis, Snakes physiology, Viper Venoms toxicity
- Abstract
The Gaboon viper has acquired an impressive reputation which is at least partly unfounded. This handsome animal with such striking features is undoubtedly docile which accounts for the very low incidence of bite amongst humans. There are only six detailed clinical reports on the effect of bite and these are summarized in the review. The viper does indeed produce prodigious amounts of venom, but the toxicity, weight for weight, is rather low compared to other poisonous snakes. Venom extractions have been carried out on four snakes over a 13-year-period and the effects of this venom have been studied in a variety of experimental animals. Systemic envenomation is characterized by immediate abrupt hypotension, subsequent cardiac damage and dyspnoea. The individual venom components responsible for these effects have not been isolated but it seems likely that the two enzymes which have been studied extensively (phospholipase A2 and the thrombin-like enzyme, gabonase) do not contribute significantly to lethality. We propose three principal activities which give rise to the major signs of systemic envenomation. Haemorrhagin; causing widespread damage to microvasculature which leads to the pulmonary oedema and hence dyspnoea, and locally causes blistering. Cardiotoxin; a long-acting material causing cardiac muscle damage, arrhythmia and ultimately cardiac failure. Peripheral vasodilator; a short acting effect, operating either locally via bradykinin formation and/or unknown peptides or centrally on the vasomotor centre.
- Published
- 1984
- Full Text
- View/download PDF
47. Artificial respiration and survival time in anaesthetized rat after injection of gaboon viper (Bitis gabonica) venom.
- Author
-
Gattullo D, Losano G, Marsh NA, Pagliaro P, Vacca G, and Vono P
- Subjects
- Animals, Bradycardia chemically induced, Pulmonary Gas Exchange, Rats, Time Factors, Positive-Pressure Respiration, Viper Venoms toxicity
- Published
- 1986
48. Sites of action of Mojave toxin isolated from the venom of the Mojave rattlesnake.
- Author
-
Gopalakrishnakone P, Hawgood BJ, Holbrooke SE, Marsh NA, Santana De Sa S, and Tu AT
- Subjects
- Animals, Antivenins pharmacology, Binding Sites drug effects, Electric Stimulation, Heart drug effects, In Vitro Techniques, Lung pathology, Male, Membrane Potentials drug effects, Mice, Muscle Contraction drug effects, Muscle, Smooth, Vascular drug effects, Myocardial Contraction drug effects, Necrosis chemically induced, Rabbits, Rats, Crotalid Venoms pharmacology, Toxins, Biological pharmacology
- Abstract
1 Mojave toxin isolated from the venom of the Mojave rattlesnake (Crotalus scutulatus scutulatus) produced an irreversible blockade of the contractile response of the mouse hemidiaphragm to stimulation of the phrenic nerve in vitro, at concentrations of 0.16 to 20 mug/ml; the response to direct stimulation was not affected over a testing period of several hours.2 Mojave toxin (1 to 4 mug/g) was injected into the tail vein of mice and the intoxicated hemidiaphragm preparation was removed either for testing the contractile response or for intracellular recording.3 In fully intoxicated hemidiaphragms the contractile response to indirect stimulation was either small and transient or absent, whilst the response to direct stimulation was well maintained.4 Intracellular recording showed that resting membrane potentials of the muscle fibres were within the normal range. Endplates were difficult to locate but miniature endplate potentials (m.e.p.ps) were recorded at sites at which neurally evoked responses either could not be detected or did not exceed 2 mV which corresponds to transmitter release of a few quanta only.5 The mean frequency of m.e.p.ps at fully intoxicated endplates was not significantly different from controls but potassium depolarization produced only a small increase in m.e.p.p. frequency relative to the control response. A 50 Hz tetanus had no effect on m.e.p.p. frequency.6 When a sub-lethal dose (3 mug) of Mojave toxin was injected into one hindlimb of mice and the tissues examined at 72 h, there was histological evidence of myonecrosis.7 The isolated perfused heart of the rat was exposed to recycled Mojave toxin (50 and 100 mug/ml) but showed no change in rate or force of ventricular contraction.8 Post-mortem examination of intoxicated mice showed a frequent incidence of localized areas of interstitial and intra-alveolar haemorrhage in the lungs. Other organs including skin and muscle were not affected.9 Mojave toxin showed antigenic similarities to crotoxin, the lethal neurotoxin in the venom of the South American rattlesnake, as determined by the ability of antiserum raised against crotoxin to neutralize Mojave toxin.10 With systemic Mojave intoxication of rapid onset, the cause of death was respiratory paralysis. However, the toxin acts at multiple sites at differing rates of action. With a slower rate of intoxication, impaired respiration may act synergistically with cardiovascular changes to produce circulatory failure. The desirability of using an antivenin with a high titre against Mojave toxin is indicated.
- Published
- 1980
- Full Text
- View/download PDF
49. Effects of envenomation on cardiac cell permeability [proceedings].
- Author
-
Marsh NA, Smith IC, and Whaler BC
- Subjects
- Animals, Calcium metabolism, Cell Membrane Permeability drug effects, In Vitro Techniques, Potassium metabolism, Rats, Bee Venoms pharmacology, Myocardium metabolism, Viper Venoms pharmacology
- Published
- 1979
50. The effect of pentosan polysulphate (SP54) on the fibrinolytic enzyme system--a human volunteer and experimental animal study.
- Author
-
Marsh NA, Peyser PM, Creighton LJ, Mahmoud M, and Gaffney PJ
- Subjects
- Administration, Oral, Adult, Animals, Female, Humans, Injections, Subcutaneous, Male, Pentosan Sulfuric Polyester administration & dosage, Rats, Rats, Inbred Strains, Thrombosis drug therapy, Tissue Plasminogen Activator metabolism, Vena Cava, Inferior, Fibrinolysis drug effects, Pentosan Sulfuric Polyester pharmacology, Polysaccharides pharmacology
- Abstract
Pentosan polysulphate causes an increase in plasminogen activator activity in plasma both after oral ingestion and after subcutaneous injection. The effect is greatest after 3 h and has disappeared by 6 h. Repeat doses by mouth over 5 days elicit a similar response. The recorded increase in activity is due largely to the release of tissue-type plasminogen activator (tPA) from the endothelium according to the antigen assay although there could be a small contribution from Factor XII-related "intrinsic" fibrinolysis induced in vitro. SP54 enhances activity ex vivo by a non-specific surface effect, and this phenomenon may contribute the increased levels of activity seen in vitro. Administration of SP54 to animals elicits a similar increase in activator activity, the intramuscular route being slightly more effective. Results with an inferior vena cava thrombosis model in the rat suggest that pentosan polysulphate may induce a thrombolytic effect.
- Published
- 1985
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.